Liging, Nasri M.
HRN: 22-24-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2023
CEFTRIAXONE 1G (VIAL)
08/22/2023
08/28/2023
IV
320mg
Q24
Apthous Stomatitis; Tc Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamSkin & Soft TissueEye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes